CLINICAL_TRIALS
trial_result
· 2014-03-05
Clinical Trial Update: A Study in Pediatric Participants With Generalized Anxiety Disorder [Phase 3]
Summary
A Phase 3 pediatric study for generalized anxiety disorder has completed, with results posted in March 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Anxiety Neuroses, Anxiety States, Neurotic | Phase 3 | Status: COMPLETED | Results posted: 2014-03-05